Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.
Neglected diseases represent a major health problem. It is estimated that one third of the world population is infected with tuberculosis (TB). Besides TB, Chagas disease, affects approximately 20 million people. Quinoxalines display great activities against TB and Chagas. Forty new quinoxaline 1...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | info:eu-repo/semantics/article |
Language: | eng |
Published: |
MDPI
2012
|
Subjects: | |
Online Access: | https://hdl.handle.net/10171/23599 |